Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine for Post-operative Pain in Mohs Micrographic Surgery
NCT04362566Phase 4Completed
- Sponsor
- University of Missouri
- Start
- Jul 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by University of Missouri. Primary endpoint: 24 Hour Pain Control. Started Jul 2020; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04362566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04362566.